Microsoft Corp MSFT:NASDAQ

Last Price$201.04Cboe Real-Time Last Sale as of 1:19PM ET 10/30/20
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-3.68(1.80%)
Bid (Size)$201.05 (27)
Ask (Size)$201.10 (36)
Day Low / High$199.62 - 204.29
Volume18.0 M

Insider Trends: Insider Sale at Revance Therapeutics Slowing 90-Days of Buying

9:23PM ET 9/30/2020 MT Newswires
Aubrey Rankin, Director and President, Innovation & Tech, on Sep 28, 2020, sold 33,119 shares in Revance Therapeutics (RVNC) for $867,055. Subsequent to the Form 4 filing with the SEC, Rankin controls a total of 819,095 shares of company stock, with 67,871 shares held directly and 751,224 owned indirectly. The market value of the direct and indirect holdings, based on the prior-day closing price, is approximately $21.1 million.

In the 90 days prior to the date of this filing, there has been one additional insider transaction which has resulted in the acquisition of 667,292 of company shares. This compares with the preceding 90-day window of time where there were 10 transactions from 9 insiders which resulted in the net acquisition of 43,331 shares.

This is lower than the average level of insider transactions in the 324-company Bio Therapeutic Drugs peer group over the last 90-day period. Within the peer group activity averaged 51.5 transactions per company, with company insiders acquiring on average 22,487 shares.

SEC Story Link